?-Synuclein Interacts with Lipoproteins in Plasma #MMPMID28887769
Emamzadeh FN; Allsop D
J Mol Neurosci 2017[]; 63 (2): 165-72 PMID28887769show ga
Parkinson?s disease (PD) is an age-related neurodegenerative disorder characterized by dopaminergic neural cell death in the substantia nigra of the brain and ?-synuclein (?-syn) accumulation in Lewy bodies. ?-Syn can be detected in blood and is a potential biomarker for PD. It has been shown recently that ?-syn can pass through the blood-brain barrier (BBB), but the mechanism is not yet understood. We hypothesized that ?-syn could interact with lipoproteins, and in association with these particles, could pass through the BBB. Here, we show that apoE, apoJ, and apoA1, but not apoB, were co-immunocaptured along with ?-syn from human blood plasma, suggesting that ?-syn is associated with high-density lipoproteins (HDL). This association was also supported by experiments involving western blotting of plasma fractions separated by gel filtration, which revealed that ?-syn was found in fractions identified as HDL. Interestingly, we could also detect ?-syn and ApoJ in the intermediate fraction between HDL and LDL, referred to as lipoprotein (a) (Lp(a)), which has an important role in cholesterol metabolism. Overall, the results provide best support for the hypothesis that ?-syn interacts with HDL, and this has potential implications for transport of ?-syn from the brain to peripheral blood, across the BBB.
free
free
free
J+Mol+Neurosci 2017 ; 63 (2): 165-72
